Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schaberg

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Pneumologie (Stuttgart, Germany)|July 17, 2004
[Inhalative antimicrobial treatment of bronchiectasis]T Schaberg
The European Respiratory Journal|August 1, 1995
The dark side of antituberculosis therapy: adverse events involving liver functionT Schaberg
Pneumologie (Stuttgart, Germany)|February 1, 1996
[The same procedure as every year]T Schaberg
MMW Fortschritte Der Medizin|November 6, 2001
[Epidemiology of tuberculosis. Continued increase in resistant pathogens?]T Schaberg
Deutsche Medizinische Wochenschrift (1946)|June 21, 1996
[Angiotensin-converting enzyme as a follow-up parameter in sarcoidosis]T Schaberg
Pneumologie (Stuttgart, Germany)|September 29, 2000
[Protective vaccination against pneumococci]T Schaberg
Deutsche Medizinische Wochenschrift (1946)|March 28, 2013
[Tuberculosis: new treatment options and updated recommendations]T Schaberg
Der Internist|December 4, 2015
[Treatment of tuberculosis. Current standards]T Schaberg
Pneumologie (Stuttgart, Germany)|December 19, 2001
[Protective vaccination against pneumococci]T Schaberg
Pneumologie (Stuttgart, Germany)|January 16, 2003
[Diagnosis, therapy, and prevention of influenza]T Schaberg
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Pneumologie (Stuttgart, Germany)|July 17, 2004
[Inhalative antimicrobial treatment of bronchiectasis]T Schaberg
The European Respiratory Journal|August 1, 1995
The dark side of antituberculosis therapy: adverse events involving liver functionT Schaberg
Pneumologie (Stuttgart, Germany)|February 1, 1996
[The same procedure as every year]T Schaberg
MMW Fortschritte Der Medizin|November 6, 2001
[Epidemiology of tuberculosis. Continued increase in resistant pathogens?]T Schaberg
Deutsche Medizinische Wochenschrift (1946)|June 21, 1996
[Angiotensin-converting enzyme as a follow-up parameter in sarcoidosis]T Schaberg
Pneumologie (Stuttgart, Germany)|September 29, 2000
[Protective vaccination against pneumococci]T Schaberg
Deutsche Medizinische Wochenschrift (1946)|March 28, 2013
[Tuberculosis: new treatment options and updated recommendations]T Schaberg
Der Internist|December 4, 2015
[Treatment of tuberculosis. Current standards]T Schaberg
Pneumologie (Stuttgart, Germany)|December 19, 2001
[Protective vaccination against pneumococci]T Schaberg
Pneumologie (Stuttgart, Germany)|January 16, 2003
[Diagnosis, therapy, and prevention of influenza]T Schaberg
Pageof 18